Infection prevention and control experts halted a 24-patient outbreak of Burkholderia cepacia in critically ill children after identifying docusate, a liquid stool softener, as the underlying source of the bacteria. Details of the six-month investigation led to a national recall of all liquid products manufactured by PharmTech.